garcinol has been researched along with Colorectal Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Das, SK; Dasi, R; Dutta, D; Ganguly, S; Gaonkar, RH; Mukherjee, B; Paul, B | 1 |
1 other study(ies) available for garcinol and Colorectal Neoplasms
| Article | Year |
|---|---|
Inhibitory potential of iRGD peptide-conjugated garcinol-loaded biodegradable nanoparticles in rat colorectal carcinoma.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Colorectal Neoplasms; Humans; Nanoparticles; Oligopeptides; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rats; Terpenes; Tissue Distribution | 2022 |